BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for April 15, 2025

April 15, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bristol Myers Squibb, Illumina, Imperative, Optellum, Nanowear, Satio, Tempus.
Read More

Other news to note for April 15, 2025

April 15, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accord, Amgen, Coherus, Intas, Kinnate, Sandoz, Sumitomo, Third Harmonic, Xoma Royalty.
Read More

Other news to note for April 15, 2025

April 15, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Evenus, Fresenius Kabi, Hengrui, Kalvista, Kaken, Oncozenge, Opthea, Pacira.
Read More

Other news to note for April 14, 2025

April 14, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carmat, Elutia, Sequana Medical, Vicarious Surgical.
Read More

Other news to note for April 14, 2025

April 14, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Opthea, Oncozenge.
Read More

Other news to note for April 11, 2025

April 11, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Basel Medical Group, Biosymetrics, Bethesda Medical, Cagent Vascular, Daxor, Green Earth Biomedical, Keensight Capital, Motion Informatics, Niox.
Read More

Other news to note for April 11, 2025

April 11, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atossa, Keros, Nona, Revive, Tempest, Tevogen, Torpedo.
Read More

Other news to note for April 10, 2025

April 10, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chemeleon, Drummond, GE Healthcare, Innoblative, Nextech, Ocuco, Ondine, Prapela.
Read More

Other news to note for April 10, 2025

April 10, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Ayala, Biosymetrics, Makana, OS Therapies, QumulusAI, Renovaro, Tonix, Vincerx.
Read More

Other news to note for April 10, 2025

April 10, 2025
Additional early-stage research and drug discovery news in brief, from: Rondo Therapeutics.
Read More
Previous 1 2 … 52 53 54 55 56 57 58 59 60 … 1396 1397 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing